The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

Epigenetics are one of life's primary drivers of adaptations. They are why human beings who live at high altitude have more ...

Kenya, once a leader in malaria vaccine trials, now lags behind in adopting the R21/Matrix-M vaccine, a more cost-effective ...

A molecular quality-control system in Anopheles mosquitoes-the species responsible for most of the world's malaria cases-is a ...

Malaria season begins this month in a large part of Africa. No disease is deadlier on the continent, especially for children.

BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...

Guest Column - Malaria remains one of Kenya's greatest public health challenges, with children under five bearing the heaviest burden. The country has been at the forefront of malaria vaccine trials ...

As part of efforts to eradicate malaria, which claims hundreds of thousands of lives annually in Africa, the lawmaker ...

GULU, UGANDA | THE INDEPENDENT | Gulu District’s Health Department has announced plans to roll out the new malaria vaccine, ...

Malaria remains the leading cause of illness and death among children under five in Uganda Kampala, Uganda | RONALD MUSOKE ...

In a decisive move to combat malaria, the Ugandan government has made it mandatory for all six-month-old babies to receive ...

Nigeria is missing from the list of countries on track to secure the World Health Organisation (WHO) vaccine approval due to ...